Literature DB >> 20443813

Right drug-right patient-right time: personalized medicine coalition.

Edward Abrahams1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 20443813      PMCID： PMC5439586          DOI： 10.1111/j.1752-8062.2008.00003.x

Source DB:  PubMed          Journal:  Clin Transl Sci        ISSN： 1752-8054            Impact factor:   4.689


× No keyword cloud information.
  1 in total

1.  Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges.

Authors:  P A Deverka; T Doksum; R J Carlson
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875
  1 in total
  10 in total

1.  Sex-dependent differences for larkspur (Delphinium barbeyi) toxicosis in yearling Angus cattle1.

Authors:  Benedict T Green; John W Keele; Dale R Gardner; Kevin D Welch; Gary L Bennett; Daniel Cook; James A Pfister; T Zane Davis; Clint A Stonecipher; Stephen T Lee; Bryan L Stegelmeier
Journal:  J Anim Sci       Date:  2019-03-01       Impact factor: 3.159

2.  Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system.

Authors:  Elizabeth Lipschultz; Keith Danahey; Tien M Truong; Emily Schierer; Samuel L Volchenboum; Mark J Ratain; Peter H O'Donnell
Journal:  JAMIA Open       Date:  2021-08-27

3.  Are We Prepared for Precision Public Health? An Examination of Genomics Content in Graduate Public Health Programs.

Authors:  Karen L Niemchick; Ally Goerge; Amy H Ponte
Journal:  Public Health Rep       Date:  2021-10-25       Impact factor: 3.117

Review 4.  Research Review: Brain network connectivity and the heterogeneity of depression in adolescence - a precision mental health perspective.

Authors:  Rajpreet Chahal; Ian H Gotlib; Amanda E Guyer
Journal:  J Child Psychol Psychiatry       Date:  2020-05-26       Impact factor: 8.982

5.  Efficacy of a Community-Based Physical Activity Program KM2H2 for Stroke and Heart Attack Prevention among Senior Hypertensive Patients: A Cluster Randomized Controlled Phase-II Trial.

Authors:  Jie Gong; Xinguang Chen; Sijian Li
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

6.  Persistent effect at 30-month post intervention of a community-based randomized trial of KM2H2 in reducing stroke and heart attack among senior hypertensive patients.

Authors:  Jie Gong; Yunan Xu; Xinguang Chen; Niannian Yang; Fang Li; Yaqiong Yan
Journal:  Int J Behav Nutr Phys Act       Date:  2018-01-02       Impact factor: 6.457

7.  Revisiting patient expectations and experiences of antibiotics in an era of antimicrobial resistance: Qualitative study.

Authors:  Olga Boiko; Martin C Gulliford; Caroline Burgess
Journal:  Health Expect       Date:  2020-07-14       Impact factor: 3.377

8.  Scenarios for 3D printing of personalized medicines - A case study.

Authors:  Netta Beer; Ingrid Hegger; Susanne Kaae; Marie Louise De Bruin; Natalja Genina; Teresa Leonardo Alves; Joelle Hoebert; Sofia Kälvemark Sporrong
Journal:  Explor Res Clin Soc Pharm       Date:  2021-09-25

Review 9.  Modelling kidney disease using ontology: insights from the Kidney Precision Medicine Project.

Authors:  Edison Ong; Lucy L Wang; Jennifer Schaub; John F O'Toole; Becky Steck; Avi Z Rosenberg; Frederick Dowd; Jens Hansen; Laura Barisoni; Sanjay Jain; Ian H de Boer; M Todd Valerius; Sushrut S Waikar; Christopher Park; Dana C Crawford; Theodore Alexandrov; Christopher R Anderton; Christian Stoeckert; Chunhua Weng; Alexander D Diehl; Christopher J Mungall; Melissa Haendel; Peter N Robinson; Jonathan Himmelfarb; Ravi Iyengar; Matthias Kretzler; Sean Mooney; Yongqun He
Journal:  Nat Rev Nephrol       Date:  2020-09-16       Impact factor: 28.314

10.  Geographical Variation in Medication Prescriptions: A Multiregional Drug-Utilization Study.

Authors:  Veronica Russo; Valentina Orlando; Valeria Marina Monetti; Federica Galimberti; Manuela Casula; Elena Olmastroni; Elena Tragni; Enrica Menditto
Journal:  Front Pharmacol       Date:  2020-05-05       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.